Evidence map›Paper›PMID 32829052›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

COVID-19 epidemic monitoring after non-pharmaceutical interventions: The use of time-varying reproduction number in a country with a large migrant population.

Adil Al Wahaibi, Abdullah Al Manji, Amal Al Maani, Bader Al Rawahi, Khalid Al Harthy, Fatma Alyaquobi, Amina Al-Jardani, Eskild Petersen, Seif Al Abri

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Effects of COVID-19 on mortality: A 5-year population-based study in Oman.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  18. Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adil Al WahaibiDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman. Electronic address: adilwahaibi@gmail.com.
Abdullah Al ManjiDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Amal Al MaaniDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Bader Al RawahiDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Khalid Al HarthyDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Fatma AlyaquobiDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Amina Al-JardaniDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Eskild PetersenDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.
Seif Al AbriDirectorate General for Disease Surveillance and Control, Ministry of Health, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19's emergence carries with it many uncertainties and challenges, including strategies to manage the epidemic. Oman has implemented non-pharmaceutical interventions (NPIs) to mitigate the impact of COVID-19. However, responses to NPIs may be different across different populations within a country with a large number of migrants, such as Oman. This study investigated the different responses to NPIs, and assessed the use of the time-varying reproduction number (R

methodsPolymerase chain reaction (PCR) laboratory-confirmed COVID-19 data for Oman, from February 24 to June 3, 2020, were used alongside demographic and epidemiological information. Data were arranged into pairs of infector-infectee, and two main libraries of R software were used to estimate reproductive number (R

findingsA total of 13,538 cases were included, 44.9% of which were Omanis. Among all these cases we identified 2769 infector-infectee pairs for calculating R

interpretationUse of real-time estimation of R

Indexed as

Epidemiological MonitoringTransients and MigrantsBetacoronavirusCoronavirus InfectionsCOVID-19HumansOmanPandemicsPneumonia, ViralPublic HealthSARS-CoV-2COVID-19 epidemiologyPublic health interventionReproductive number

Identifiers

PMID32829052
PMCPMC7439014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.